1-[2-(trifluoromethyl)benzoyl]-1,4-diazepane
![1-[2-(trifluoromethyl)benzoyl]-1,4-diazepane price.](/CAS/20180808/GIF/926193-49-9.gif)
|
- $983.52 - $1928.08
- Product name: 1-[2-(trifluoromethyl)benzoyl]-1,4-diazepane
- CAS: 926193-49-9
- MF: C13H15F3N2O
- MW: 272.27
- EINECS:
- MDL Number:MFCD09044057
- Synonyms:1-[2-(trifluoromethyl)benzoyl]-1,4-diazepane;Methanone, (hexahydro-1H-1,4-diazepin-1-yl)[2-(trifluoromethyl)phenyl]-
3 prices
Selected condition：
Brand
- American Custom Chemicals Corporation
Package
- 1G
- 2.5G
- 5G
- ManufacturerAmerican Custom Chemicals Corporation
- Product numberHCH0051901
- Product description1-[2-(TRIFLUOROMETHYL)BENZOYL]-1,4-DIAZEPANE 95.00%
- Packaging5G
- Price$1928.08
- Updated2021-12-16
- Buy
- ManufacturerAmerican Custom Chemicals Corporation
- Product numberHCH0051901
- Product description1-[2-(TRIFLUOROMETHYL)BENZOYL]-1,4-DIAZEPANE 95.00%
- Packaging2.5G
- Price$1473.14
- Updated2021-12-16
- Buy
- ManufacturerAmerican Custom Chemicals Corporation
- Product numberHCH0051901
- Product description1-[2-(TRIFLUOROMETHYL)BENZOYL]-1,4-DIAZEPANE 95.00%
- Packaging1G
- Price$983.52
- Updated2021-12-16
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| American Custom Chemicals Corporation | HCH0051901 | 1-[2-(TRIFLUOROMETHYL)BENZOYL]-1,4-DIAZEPANE 95.00% | 5G | $1928.08 | 2021-12-16 | Buy |
| American Custom Chemicals Corporation | HCH0051901 | 1-[2-(TRIFLUOROMETHYL)BENZOYL]-1,4-DIAZEPANE 95.00% | 2.5G | $1473.14 | 2021-12-16 | Buy |
| American Custom Chemicals Corporation | HCH0051901 | 1-[2-(TRIFLUOROMETHYL)BENZOYL]-1,4-DIAZEPANE 95.00% | 1G | $983.52 | 2021-12-16 | Buy |
Properties
Boiling point :376.1±42.0 °C(Predicted)
Density :1.227±0.06 g/cm3(Predicted)
pka :9.94±0.20(Predicted)
Density :1.227±0.06 g/cm3(Predicted)
pka :9.94±0.20(Predicted)
Safety Information
| Symbol(GHS): | ||||||||
|---|---|---|---|---|---|---|---|---|
| Signal word: | ||||||||
| Hazard statements: |
|
|||||||
| Precautionary statements: |
|